Table 1.
Demographic and baseline characteristics for FDT and TAU groups
| FDT N = 16 | TAU N = 17 | |
|---|---|---|
| Age (years) | ||
| Mean, SD | 54.69, 12.59 | 50.29, 13.86 |
| Min, max | 25, 73 | 24, 79 |
| Gender, n (%) | ||
| Female | 12(75%) | 12(71%) |
| Male | 4(25%) | 5(21%) |
| Race, n (%) | ||
| African American | 3(19%) | 6(35%) |
| Caucasian | 12(75%) | 11(65%) |
| Hispanic | 1 (6%) | – |
| Comorbid psychiatric disorders | ||
| Personality disorders | 4(25%) | 3(18%) |
| Anxiety disorders | 4(25%) | 6(35%) |
| Substance use disorders | 5(31%) | 2(12%) |
| Other psychiatric disorders | 2(12.5%) | – |
| Number of patients on psychotropic medication during group treatment, n | 13 | 15 |
| Medications in use, n | ||
| Selective serotonin reuptake inhibitor | 6 | 8 |
| Selective norepinephrine reuptake inhibitor | 6 | 3 |
| Tetracyclic antidepressants | 7 | 2 |
| Norepinephrine‐dopamine reuptake inhibitor | 5 | 7 |
| Other antidepressants | 0 | 2 |
| Benzodiazepines | 3 | 8 |
| Atypical antipsychotics | 2 | 3 |
| *Patients could be on multiple agents | ||